| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/17/2007 | USRE39573 Antimutagenic compositions for treatment and prevention of photodamage to skin |
| 04/17/2007 | US7206639 Cochlear drug delivery system and method |
| 04/17/2007 | US7206623 Optical sampling interface system for in vivo measurement of tissue |
| 04/17/2007 | US7205378 therapeutic agent is reversibly immobilized on polymer matrix using ionic complexation between latent carboxylic groups present on the lactone bearing polymer matrix and a cationic group on the therapeutic agent; drug delivery |
| 04/17/2007 | US7205343 Stabilized bioactive preparations and method of use |
| 04/17/2007 | US7205282 Remedies for hepatitis |
| 04/17/2007 | US7205279 Pharmaceutical compositions |
| 04/17/2007 | US7205277 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205276 Zinc-free and low-zinc insulin preparations having improved stability |
| 04/17/2007 | US7205273 Fusogenic liposomes |
| 04/17/2007 | US7205006 Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same |
| 04/17/2007 | US7205003 Method and topical formulation for treating skin conditions associated with aging |
| 04/17/2007 | US7205001 Anticancer agents; using potassium arsenite therapy and radiation |
| 04/17/2007 | US7204999 Method of production of nanoparticle and nanoparticle produced by the method of production |
| 04/17/2007 | US7204998 For use in perfumed, food, beverage or pharmaceutical products; reduced occurrence or an explosion of reduced violence when suspended in hot air during their preparation |
| 04/17/2007 | US7204997 Responsive microgel and methods related thereto |
| 04/17/2007 | US7204996 Method of cancer treatment |
| 04/17/2007 | US7204995 For therapy of dry eye |
| 04/17/2007 | US7204971 Shaped microcomponents via reactive conversion of biologically-derived microtemplates |
| 04/17/2007 | US7204823 Medication delivery system and monitor |
| 04/17/2007 | CA2387915C Direct compression polymer tablet core |
| 04/17/2007 | CA2348841C Improved growth stimulant compositions |
| 04/17/2007 | CA2323734C Quick disintegrating tablet in buccal cavity and production process thereof |
| 04/17/2007 | CA2321267C Orally administrable immediate-release and prolonged-release galenic form comprising an absorption-promoting agent and use of this absorption-promoting agent |
| 04/17/2007 | CA2320731C Antibiotics in dry dosage forms for the treatment of shallow ulcers of the oral mucosa |
| 04/17/2007 | CA2313458C Device for enhancing transdermal agent flux |
| 04/17/2007 | CA2308721C Radio-opaque polymer biomaterials |
| 04/17/2007 | CA2283648C Polymeric carrier |
| 04/17/2007 | CA2261310C Novel adsorbent |
| 04/17/2007 | CA2244494C Tabletting of erythritol |
| 04/17/2007 | CA2216410C Improved inactivated vaccines |
| 04/17/2007 | CA2190357C Chewable flubendazole tablets for companion animals |
| 04/17/2007 | CA2182417C Oral dosage form containing colestipol as a carrier and acidic active substances and a process for producing the same |
| 04/17/2007 | CA2158630C Dosage forms containing thioctic acid or solid salts of thioctic acid with improved release and bioavailability |
| 04/17/2007 | CA2149420C Microporous macrocapsules |
| 04/17/2007 | CA2133205C Stable polypeptide composition |
| 04/17/2007 | CA2124260C Tetrahydropyran derivatives |
| 04/13/2007 | CA2563496A1 Nicotine transdermal preparation and production method thereof |
| 04/12/2007 | WO2007041664A1 Non-protein stabilized clostridial toxin pharmaceutical compositions |
| 04/12/2007 | WO2007041627A1 Compositions and methods for improved skin care |
| 04/12/2007 | WO2007041584A2 Implantable sensors, implantable pumps, and anti-scarring drug combinations |
| 04/12/2007 | WO2007041569A1 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 04/12/2007 | WO2007041479A2 Pharmaceutical compositions |
| 04/12/2007 | WO2007041475A2 Iontophoresis drug delivery formulation providing acceptable sensation and dermal anesthesia |
| 04/12/2007 | WO2007041409A1 Pharmaceutical compositions of a 5-ht2a serotonin receptor modulator useful for the treatment of disorders related thereto |
| 04/12/2007 | WO2007041206A2 Drug delivery nanocarriers targeted by landscape phage |
| 04/12/2007 | WO2007041190A2 Polymer-based delivery system for immunotherapy of cancer |
| 04/12/2007 | WO2007041156A2 Antibiotic formulations, unit doses, kits, and methods |
| 04/12/2007 | WO2007041119A1 Transdermal drug delivery systems, devices, and methods employing hydrogels |
| 04/12/2007 | WO2007041046A2 Soy-based thermosensitive hydrogels for controlled release systems |
| 04/12/2007 | WO2007040997A2 Pharmaceutical dosage forms having immediate release and/or controlled release properties |
| 04/12/2007 | WO2007040306A1 A solid dispersion comprising sibutramine and surfactants, and a preparation method thereof |
| 04/12/2007 | WO2007039974A1 Emulsion lotion |
| 04/12/2007 | WO2007039936A1 Compositions for application to mucosa |
| 04/12/2007 | WO2007039935A1 Solid external pharmaceutical composition |
| 04/12/2007 | WO2007039769A1 Pharmaceutical compositions stabilized in glassy particles |
| 04/12/2007 | WO2007039760A2 Use of oligouronates for treating mucus hyperviscosity |
| 04/12/2007 | WO2007039754A1 Use of oligouronates for treating mucus hyperviscosity |
| 04/12/2007 | WO2007039646A1 Transdermal delivery system for treating infertility |
| 04/12/2007 | WO2007039584A1 Multivalent liposomal vaccine compositions comprising polysaccharide antigens and a protein adjuvant |
| 04/12/2007 | WO2007039583A1 Liposomal vaccine compositions comprising a polysaccharide antigen and a protein adjuvant |
| 04/12/2007 | WO2007039533A2 Antifungal composition |
| 04/12/2007 | WO2007039420A1 Novel dosage formulation |
| 04/12/2007 | WO2007039417A1 Pharmaceutical preparation containing meloxicam |
| 04/12/2007 | WO2007039294A2 Gelling compositions and methods |
| 04/12/2007 | WO2007039201A2 Photostable pharmaceutical composition containing brivudine for the treatment of herpetic keratitis |
| 04/12/2007 | WO2007039122A2 Solid orally administerable pharmaceutical dosage forms with rapid active principle release |
| 04/12/2007 | WO2007038979A1 Effervescent metformin composition and tablets and granules made therefrom |
| 04/12/2007 | WO2007038949A1 Pharmaceutical compositions for the treatment of inner ear disorders |
| 04/12/2007 | WO2007038926A1 Solid vaccine formulation |
| 04/12/2007 | WO2007038867A1 Controlled-release oral dosage form |
| 04/12/2007 | WO2007038855A1 Medical gel |
| 04/12/2007 | WO2007006353A3 Use of a partially neutralized, anionic (meth)acrylate copolymer as a coating for the production of a medicament releasing active substance at reduced ph values |
| 04/12/2007 | WO2007004153A3 Device for the controlled release of a predefined quantity of a substance |
| 04/12/2007 | WO2006131806A3 Multiparticulates comprising low-solubility drugs and carriers that result in rapid drug release |
| 04/12/2007 | WO2006131566A3 Oral ribavirin pharmaceutical compositions |
| 04/12/2007 | WO2006128057A3 Oral dosage forms comprising progesterone and methods of making and using the same |
| 04/12/2007 | WO2006127953A3 Echogenic microbubbles and microemulsions for ultrasound-enhanced nanoparticle-mediated delivery of agents |
| 04/12/2007 | WO2006127738A3 Compressible chewing gums for delivery of actives |
| 04/12/2007 | WO2006127618A9 Compressible gum based delivery systems for the release of ingredients |
| 04/12/2007 | WO2006127561A3 Package assembly for multi-modality functional ingredients in chewing gum compositions |
| 04/12/2007 | WO2006125496A3 Pharmaceutical formulations comprising active pharmaceutical principles absorbed on titanium dioxide nanoparticles |
| 04/12/2007 | WO2006123361A3 Microspheres containing goserelin or a pharmaceutically acceptable salt thereof |
| 04/12/2007 | WO2006122835B1 Colonic delivery of adsorbents |
| 04/12/2007 | WO2006122551A3 An implantable therapy system for treating a living being with an active factor |
| 04/12/2007 | WO2006122550A3 Storage container comprising an implantable therapy system |
| 04/12/2007 | WO2006122549A3 An implantable therapy system comprising a gripping element |
| 04/12/2007 | WO2006119844A3 Controlled release oral drug delivery system |
| 04/12/2007 | WO2006101882A3 Medicament delivery formulations, devices and methods |
| 04/12/2007 | WO2006100595A3 Chewing gum compositions of varenicline |
| 04/12/2007 | WO2006100281A3 Solubilized ibuprofen |
| 04/12/2007 | WO2006097943A3 Pharmaceutical compositions of amlodipine and benazepril |
| 04/12/2007 | WO2006077334A3 Medicament that is intended for oral administration, comprising a cyclooxygenase-2 inhibitor, and preparation method thereof |
| 04/12/2007 | WO2006062683A3 Treatment and prevention of epilepsy |
| 04/12/2007 | WO2006023985A9 System and method for modifying a fluid for oral administration |
| 04/12/2007 | WO2006021692A8 Pharmaceutical composition in the form of a gastric-resident tablet containing an active principle |
| 04/12/2007 | US20070083139 Adhesive preparations |
| 04/12/2007 | US20070082970 Adhesives and their applications |
| 04/12/2007 | US20070082945 Discodermolide compositions |
| 04/12/2007 | US20070082938 Polymorphs of bicifadine hydrochloride |